htasurv: a Stata module for performing survival analysis in economic evaluations

Jan 2, 2017

Written by David Trueman, Director

htasurv is an open source Stata module for assessing alternative parametric distributions when extrapolating survival data for use in health economic models. The function distfind loops through alternative distributions (specified by the user) and reports statistics and produces plots specified in NICE DSU TSD 14.0. The function distanalysis writes out results and useful statistics (e.g. the variance-covariance matrix) for the analyst. The module can be installed directly from github, using the github module. Once the github module is installed, installation of htasurv is:

github install sourceHEOR/htasurv

Syntax
For distfind:

distfind [varlist], dlist(string) timevar(varname) failure(varname) [GRaphs]

Where varlist are the variables in the survival model (often treatment), timevar is the variable defining the time-to-event, and failure is a binary variable for failure vs censoring (1=failure, 0=censored). If the graphs option is used, plots will be saved to curentdirectory/graphs. dlist is the list of distributions to estimate as lowercase strings (see example below). For distanalysis:

distanalysis [varlist], sdist(string) doctitle(string) [caption(string)] [fname(string)]

distanalysis will estimate the model with variables given in varlist with distribution given in sdist (full title; all lowercase). The resulting model will be written to .csv and .rtf files with file names given by doctitle. If a folder location is specified by fname, all files will be stored there (otherwise, the current directory is used).

Example use

sysuse cancer.dta, clear

global dlist “gamma weibull gompertz exponential lognormal loglogistic”

distfind age i.drug, dlist($dlist) timevar(studytime) failure(died)

distanalysis age i.drug, sdist(gompertz) doctitle(test) caption(“Gompertz”)

The software can be downloaded here. This software is released under the GNU General Public License version 3.


More Insights

Obtaining a NICE recommendation for your medical device: a view from the external assessors

Obtaining a NICE recommendation for your medical device: a view from the external assessors

Written by Mark Pennington, Consultant Health Economist A National Institute for Health and Care Excellence (NICE) recommendation can open the door to widespread adoption for a new medical device. But does getting a NICE recommendation require ... Read more

10 steps for a successful global economic model

10 steps for a successful global economic model

Written by Beth Hancock, Senior Consultant Health Economist Pharmaceutical companies often develop global cost-effectiveness and budget impact models, with the aim of adapting them for specific countries. In principle, this is an efficient and ... Read more

Conceptual modelling and NICE requirements: a significant change or hill of beans?

Conceptual modelling and NICE requirements: a significant change or hill of beans?

Written by Alec Miners, Head of Health Economics The National Institute for Health and Care Excellence’s (NICE’s) new processes and methods guide includes several important changes to the way submitted economic evaluations should be ... Read more

British Heart Week 2022

British Heart Week 2022

As we approach the end of British Heart Week, we reflect on some of the key stats around heart conditions in the UK and our contribution as a company to help bring cutting-edge treatments to patients with cardiovascular diseases Read more